1.0PRISM BioLabhttps://prismbiolab.com/jarich600338<blockquote class="wp-embedded-content" data-secret="Ud7KsG1Wjw"><a href="https://prismbiolab.com/ja/team-showcase/takamitsu-maru/">丸 喬光</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://prismbiolab.com/ja/team-showcase/takamitsu-maru/embed/#?secret=Ud7KsG1Wjw" width="600" height="338" title="“Takamitsu Maru” — PRISM BioLab" data-secret="Ud7KsG1Wjw" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://prismbiolab.com/wp-includes/js/wp-embed.min.js </script>https://prismbiolab.com/wp-content/uploads/2025/09/Takamitsu-Maru_SU2_9175-2-copy-1024x1024.jpg10241024Takamitsu Maru is responsible for efficacy pharmacology in PRISM BioLab. He has a long experience of compound screening and evaluation for about 20 years at Takeda Pharma and Axcelead DDP. From 2025, he joined PRISM BioLab. Especially, he had contributed to making drug discovery research efficient by developing the preparing method of membrane proteins and […]